Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 5 NIH 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 497 Neoplasms 302 Breast Neoplasms 294 Colorectal Neoplasms 228 Neoplasm Metastasis 194 Prostatic Neoplasms 175 Ovarian Neoplasms 173 Lung Neoplasms 159 Multiple Myeloma 158 Recurrence 131 Melanoma 125 Pancreatic Neoplasms 115 Squamous Cell Carcinoma of Head and Neck 104 Stomach Neoplasms 102 Leukemia, Myeloid, Acute 101 Endometrial Neoplasms 101 Small Cell Lung Carcinoma 88 Leukemia, Lymphocytic, Chronic, B-Cell 87 Triple Negative Breast Neoplasms 84 Lymphoma, Non-Hodgkin 84 Carcinoma, Renal Cell 83 Carcinoma, Hepatocellular 79 Urinary Bladder Neoplasms 77 Lymphoma, Large B-Cell, Diffuse 74 Lymphoma, Follicular 68 Advanced Solid Tumors 66 Lymphoma 62 Parkinson Disease 4, Autosomal Dominant Lewy Body 61 Glioblastoma 58 Head and Neck Neoplasms 56

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Lupus Erythematosus, Systemic × 90 days × Clear all

NCT07000110 2026-05-20

SIMA

AstraZeneca

Infections, Lupus Erythematosus, Systemic, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡